Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.
Investor Presentation
KWS SAAT SE | October 2015
Business performance
of the KWS Group
Plant breeding & seed business
Fundamentals
Source: DBV
48%
usable harvest
Source: FAO
42% pre-
harvest losses
10% post-
h...
Global importance of agricultural crops
217
177
163
107
49
38 34
25 26
19
6 5





704
883
722
261
134
54 62 40
138
3...
TOP 6 Global agricultural seed companies
Sales of agricultural crops
October 2015
Global sales in € bn
1.19 USD/EUR
1 Sale...
KWS core framework
October 2015Investor Presentation6
Ziele
Profitable growth  An average increase in consolidated net sa...
117
141 152
138 138
10/11 11/12 12/13 13/14 14/15
CAGR
4.2%855
986
1,147 1,178
1,260
10/11 11/12 12/13 13/14 14/15
CAGR
10...
Sales 2014/2015
Sales in € mn
714.9
351.1
107.3
4.7
1,178.0
754.4
390.5
111.3
4.2
1,260.4
Corn Sugarbeet* Cereals KWS Grou...
Total sales by region and business segment
2014/2015
October 2015
* incl. potato
Investor Presentation9
By business segmen...
EBIT 2014/2015
October 2015Investor Presentation10
EBIT in € mn
100.9
70.1
17.1
–49.7
138.4
84.2
93.0
12.0
–51.2
138.0
EBI...
Major EBIT drivers
October 2015Investor Presentation11
Major EBIT drivers in € mn
47.3
4.4
–25.2
–19.0
–2.9138.4 138.0
EBI...
October 2015Investor Presentation12
Statement of comprehensive income
in € mn, if not stated otherwise 2014/2015 2013/2014...
October 2015Investor Presentation13
Statement of comprehensive income
Reconciliation: corporate controlling structure/IFRS...
October 2015Investor Presentation14
Balance sheet - assets
at June 30, 2015
in € mn 2014/2015 2013/2014
Intangible assets ...
October 2015Investor Presentation15
Balance sheet – equity and liabilities
at June 30, 2015
in € mn 2014/2015 2013/2014
Su...
October 2015Investor Presentation16
Taxes
in € mn 2014/2015 2013/2014 +/–
Results of ordinary activities 130.1 125.8 +3.5%...
October 2015Investor Presentation17
Cash flow statement
in € mn 2014/2015 2013/2014 +/–
Net income for the year 84.0 80.3 ...
Capital expenditure 2014/2015
Strengthening of growth markets
October 2015
* incl. potato
Investor Presentation18
By regio...
Segment report
Corn Segment
Corn acreage for sowing season 2015
October 2015Investor Presentation21
0.8 1.6 2.1 2.6 3.0 3.7
4.9
7.8
15.5
36.0
37.8
Nor...
Corn EU
Sales development and market share
October 2015Investor Presentation22
259
297
314 324 321
10/11 11/12 12/13 13/14...
Corn North America
Sales development and market share
October 2015Investor Presentation23
50:50-JV with Vilmorin, France
3...
Corn other regions
Sales development
October 2015Investor Presentation24
39 50
123
145 155
10/11 11/12 12/13 13/14 14/15
C...
Sugarbeet Segment
Sugarbeet segment sales
October 2015
Total segment sales
Potato 9%
91% Sugarbeet
Segment sales
2014/2015
€390.5 mn
Investo...
Sugarbeet worldwide
Sales development and market share
October 2015Investor Presentation27
1 Sugarbeet seeds w/o potato
Ne...
Sugarbeet EU
Sales development and market share
October 2015
2 Own data KWS, 2014
1 Sugarbeet seeds w/o potato
Investor Pr...
EU sugar market regime 2017
October 2015Investor Presentation29
 Acreage expected to stay stable
 Slight acreage expansi...
What lies ahead? – New research & breeding projects:
 New breeding technologies (GABI)
 KWS & Bayer  CONVISO® SMART (no...
Cereals Segment
KWS cereals activities
October 2015
Acreage-related decline in hybrid rye business
Investor Presentation32
78
93
112 107 1...
KWS cereals activities
October 2015
Takeover of the remaining 51% of shares in MOMONT, France
Investor Presentation33
Research & Development
Research & development at KWS
Base of a successful Corporate Development
October 2015Investor Presentation35
R&D expenditu...
Research & development at KWS
Highly innovative and tailor-made
October 2015Investor Presentation36
296 303
276
336
429
10...
KWS: Global breeding
October 2015Investor Presentation37
Breeding and distribution in over 70 countries
Breeding stations
...
Genetically engineered trait
Lead gene
identification
Proof of
concept
Elite Event
selection
Deregulation Commerciali-
zat...
Corn traits from different companies
October 2015Investor Presentation39
Trait Event Event name Monsanto Syngenta DuPont/P...
Employees
October 2015Investor Presentation40
2014/2015 2013/2014 +/–
Research & development 1,985 1,836 8.1%
Distribution...
Forecast 2014/2015
KWS Group in accordance with
IFRS 11
Forecast 2015/2016
October 2015Investor Presentation42
KWS Group Sales EBIT margin R&D intensity
2015/2016 1,035 – 1,085 >...
Forecast 2015/2016
Segment report
Forecast 2015/2016
October 2015Investor Presentation44
2015/2016 2014/2015
Sales +10% to 15% € 754.4 mn
EBIT margin around...
Appendix
Principles
46
1. We optimize genetic potential through excellent research
and breeding programs.
2. We deliver best-qualit...
The Executive Board
October 2015
Dr. Hagen Duenbostel
(1970)
 CEO/Member of the
Executive Board since 2003
 Responsibili...
The KWS share
October 2015
Shareholder structure
No. of shares:
6,600,000
56.0%
Families
Büchting
Arend Oetker
Giesecke
15...
Financial calendar & IR contact
October 2015Investor Presentation49
Date
November 24, 2015 Report on the 1st quarter of 20...
Disclaimer
October 2015
These materials are not an offer for sale of Subscription rights or Securities in the United State...
Upcoming SlideShare
Loading in …5
×

KWS Investor Presentation September 2015

1,125 views

Published on

KWS Investor Presentation September 2015

Published in: Economy & Finance
  • Be the first to comment

KWS Investor Presentation September 2015

  1. 1. Investor Presentation KWS SAAT SE | October 2015
  2. 2. Business performance of the KWS Group
  3. 3. Plant breeding & seed business Fundamentals Source: DBV 48% usable harvest Source: FAO 42% pre- harvest losses 10% post- harvest losses R&D intensity of approx. 15% of consolidated net sales 1% to 2% progress in yields and development of tolerances and resistances Per capita cropland (in ha) 20001950 2050 0.5 0.3 0.2 Harvest losses (worldwide) Climate change October 2015Investor Presentation3 °C
  4. 4. Global importance of agricultural crops 217 177 163 107 49 38 34 25 26 19 6 5      704 883 722 261 134 54 62 40 138 374 13 38      Source: faostat.fao.org, May 2013 *Raw sugar value, source: zuckerverbaende.de, May 2013 Acreage 2012 (in mn ha) World production 2012 (in mn tonnes)       not part of the KWS product portfolio Trend compared to previous year Wheat Corn Barley Sorghum Rapeseed Sunflower Potato Rye Sugar- beet Catch crops October 2015Investor Presentation4
  5. 5. TOP 6 Global agricultural seed companies Sales of agricultural crops October 2015 Global sales in € bn 1.19 USD/EUR 1 Sales 2013/2014 „Seeds & Genomics“ w/o vegetables; FY: September 1 to August 31 2 Sales 2014, „Seeds“; FY: January 1 to December 31 3 Sales 2014 w/o flowers & vegetables; FY: January 1 to December 31 4 Sales 2014/2015; FY: July 1 to June 30 5 Sales 2014; „Seeds, Traits & Oils“; FY: January 1 to December 31 6 Sales 2014/2015; „Field seeds“; FY: July 1 to June 30 Sales* in Europe in € bn 1.19 USD/EUR DuPont/Pioneer Syngenta Vilmorin Dow Monsanto * Estimated sales for calendar year 2014 * Source: Phillips McDougall Consultants; own estimates KWS Investor Presentation5 At the beginning of fiscal year 2014/2015 we changed the presentation of the KWS Group’s consolidated financial statements due to an amendment to the International Financial Reporting Standards (IFRS 11). We can no longer carry the net sales and costs of our 50:50 joint ventures in the statement of comprehensive income in the KWS Group. If not stated otherwise, all figures in the following will be in accordance with our internal corporate controlling structure. Monsanto1 DuPont/Pioneer2 Syngenta3 Dow5 Vilmorin6 4 0.9 1.3 1.3 3.2 6.1 8.3 0.1 0.6 0.6 0.7 0.7 1.0
  6. 6. KWS core framework October 2015Investor Presentation6 Ziele Profitable growth  An average increase in consolidated net sales of 5% to 10% p. a.  EBIT margin > 10% Research & development  R&D intensity of 12% to 15% of consolidated sales  1% to 2% progress in yields p. a. for our customers and development of tolerances and resistances Internationalization  Foreign sales > 80%  Expansion of the portfolio of varieties for subtropical markets Sustainability  Integration of international subsidiaries Dividend  A dividend payout ratio of 20% to 25% of the KWS Group’s net  income for the year The KWS Group’s medium- and long-term objectives KWS seeds the future. Our high-performing seeds and thorough knowledge of agriculture make us the trusted supplier for generations of farmers. This is our contribution in addressing growing global food demand.
  7. 7. 117 141 152 138 138 10/11 11/12 12/13 13/14 14/15 CAGR 4.2%855 986 1,147 1,178 1,260 10/11 11/12 12/13 13/14 14/15 CAGR 10.2% EBIT in € mn EBIT margin 2014/2015: 10.9% Sales in € mn in € mn 2014/2015 2013/2014 Sales 986.0 923.5 EBIT 113.4 118.3 KWS Track Record Sales and EBIT in accordance with IFRS 11 (at equity) October 2015Investor Presentation7
  8. 8. Sales 2014/2015 Sales in € mn 714.9 351.1 107.3 4.7 1,178.0 754.4 390.5 111.3 4.2 1,260.4 Corn Sugarbeet* Cereals KWS GroupCorporate * incl. potato Sales 2013/2014 Sales 2014/2015 October 2015Investor Presentation8
  9. 9. Total sales by region and business segment 2014/2015 October 2015 * incl. potato Investor Presentation9 By business segment 60% Corn 31% Sugarbeet* Cereals 9% Total sales € 1,260.4 mn By region Germany 18% 41% Americas 36% Europe (w/o Germany) Rest of world 5% Total sales € 1,260.4 mn
  10. 10. EBIT 2014/2015 October 2015Investor Presentation10 EBIT in € mn 100.9 70.1 17.1 –49.7 138.4 84.2 93.0 12.0 –51.2 138.0 EBIT 2013/2014 EBIT 2014/2015 * incl. potato Corn Sugarbeet* Cereals KWS Group Corporate
  11. 11. Major EBIT drivers October 2015Investor Presentation11 Major EBIT drivers in € mn 47.3 4.4 –25.2 –19.0 –2.9138.4 138.0 EBIT 2013/2014 Gross margin Seling expenses R&D expenses Administrative expenses OOI/OOE balance EBIT 2014/2015 * incl. potato
  12. 12. October 2015Investor Presentation12 Statement of comprehensive income in € mn, if not stated otherwise 2014/2015 2013/2014 +/– Net sales 1,260.4 1,178.0 +7.0% Cost of sales 649.6 614.5 +5.7% Gross profit on sales 610.8 563.5 +8.4% Selling expenses 236.7 212.3 +11.5% Research & development expenses 173.8 150.0 +15.9% General and administrative expenses 80.5 76.7 +5.0% Other operating income 89.8 60.7 +47.9% Other operating expenses 71.6 46.8 +53.0% Operating income (EBIT) 138.0 138.4 –0.3% Net financial income/expenses –7.1 –12.6 –43.7% Results of ordinary activities 130.9 125.9 +4.0% Taxes 46.9 45.6 +2.9% Net income for the year 84.1 80.3 +4.6% Share of minority interests 1.3 3.2 –59.4% Net income after shares of minority interests 82.7 77.1 +7.3% Earnings per share (in €) 12.54 11.69 +6.8% In accordance with our corporate controlling structure
  13. 13. October 2015Investor Presentation13 Statement of comprehensive income Reconciliation: corporate controlling structure/IFRS 11 in € mn, if not stated otherwise Corporate controlling structure +/– IFRS 11 (at equity) Net sales 1,260.4 –274.4 986.0 Cost of sales 649.6 –196.1 453.5 Gross profit on sales 610.8 –78.3 532.5 Selling expenses 236.7 –47.7 189.0 Research & development expenses 173.8 +0.8 174.6 General and administrative expenses 80.5 –5.7 74.8 Other operating income 89.8 –1.8 88.0 Other operating expenses 71.6 –2.9 68.7 Operating income (EBIT) 138.0 –24.6 113.4 Net financial income/expenses –7.1 +23.8 16.7 Results of ordinary activities 130.9 –0.8 130.1 Taxes 46.9 –0.8 46.1 Net income for the year 84.1 –0.1 84.0 Share of minority interests 1.3 +/–0 1.3 Net income after shares of minority interests 82.7 +/–0 82.7 Earnings per share (in €) 12.54 –0.01 12.53 Reconciliation 2014/2015
  14. 14. October 2015Investor Presentation14 Balance sheet - assets at June 30, 2015 in € mn 2014/2015 2013/2014 Intangible assets 85.7 73.9 Property, plant and equipment 351.9 283.9 Equity-accounted financial assets 153.0 126.1 Financial assets 2.5 2.7 Noncurrent tax assets 4.0 4.2 Deferred tax assets 54.3 47.8 Noncurrent assets 651.4 538.7 Inventories 178.0 120.2 Biological assets 12.3 12.6 Trade receivables 309.7 297.8 Securities 67.0 69.2 Cash and cash equivalents 41.2 53.1 Current tax assets 57.5 45.3 Other current financial assets 26.7 14.9 Other current assets 11.7 13.3 Current assets 704.1 626.3 Total assets 1,355.5 1,165.0 In accordance with IFRS 11 (at equity)
  15. 15. October 2015Investor Presentation15 Balance sheet – equity and liabilities at June 30, 2015 in € mn 2014/2015 2013/2014 Subscribed capital 19.8 19.8 Capital reserve 5.5 5.5 Retained earnings 705.7 604.4 Minority interest 7.7 8.1 Equity 738.7 637.8 Long-term provisions 110.6 99.0 Long-term borrowings 181.8 113.8 Trade payables 1.6 1.5 Deferred tax liabilities 28.1 26.2 Other noncurrent liabilities 12.8 12.5 Noncurrent liabilities 334.9 253.0 Short-term provisions 87.4 74.8 Short-term borrowings 32.3 40.1 Trade payables 59.7 56.8 Current tax liabilities 30.1 35.4 Other current financial liabilities 15.9 11.6 Other current liabilities 56.5 55.4 Current liabilities 281.9 274.2 Liabilities 616.8 527.2 Total equity and liabilities 1,355.5 1,165.0 In accordance with IFRS 11 (at equity)
  16. 16. October 2015Investor Presentation16 Taxes in € mn 2014/2015 2013/2014 +/– Results of ordinary activities 130.1 125.8 +3.5% Expected income tax expense 37.9 36.6 +3.5% Difference in income tax liability outside Germany 4.2 13.6 –68.8% Tax portion for tax-free income –3.0 0.1 Tax portion for expenses not deductible for tax purposes 6.7 2.6 Tax portion for temporary differences and losses for which no deferred taxes have been recognized 0.0 0.1 Tax credits –0.3 0.0 Taxes relating to previous years 0.3 –6.8 Other tax effects 0.3 –0.7 Reported income tax expense 46.1 45.5 +1.3% Effective tax rate 35.4% 36.2% –2.1% Reasons for the increase in tax rate:  strong income growth in countries with higher tax rates  special effects amongst others due to the merger of KWS MAIS GMBH with KWS SAAT SE In accordance with IFRS 11 (at equity)
  17. 17. October 2015Investor Presentation17 Cash flow statement in € mn 2014/2015 2013/2014 +/– Net income for the year 84.0 80.3 +4.6% Cash earnings 92.1 85.0 +8.4% Net cash from operating activities 48.1 76.1 –36.8% Net cash from investing activities –123.8 63.1 Net cash from financing activities 48.4 –43.6 Cash and cash equivalents at end of year 108.2 122.3 –11.5% Thereof cash and cash equivalents 67.0 69.2 –3.2% Thereof securities 41.2 53.1 –22.4% Changes in cash and cash equivalents –14.1 –33.5 –57.9% Oktober 2015 In accordance with IFRS 11 (at equity)
  18. 18. Capital expenditure 2014/2015 Strengthening of growth markets October 2015 * incl. potato Investor Presentation18 By region Germany 24% Americas 25% 43% Europe (w/o Germany) Rest of world 8% Capital expenditure € 140.6 mn By business segment 37% Corn 17% Sugarbeet* 32% Cereals Corporate 14% Capital expenditure € 140.6 mn
  19. 19. Segment report
  20. 20. Corn Segment
  21. 21. Corn acreage for sowing season 2015 October 2015Investor Presentation21 0.8 1.6 2.1 2.6 3.0 3.7 4.9 7.8 15.5 36.0 37.8 Northern Europe Central Europe Southern Europe Germany France Argentinia South East Europe Eastern Europe Brazil North America China Market volume 2014/2015* (in mn ha) EU 28: 13.6 mn ha (–3%) Europa (excl. CH, incl. TR, UA, RU): 22.4 mn ha (–4%) NE: DK, UK, NL, BE; SOE: HU, BG, AT, RO, RS, HR; NA: US; ME: PL, CZ, SK; SE: IT, ES, PT; OE: RU, UA * Priliminary data Source: Kleffmann; KWS; USDA; Statistical Office of China; Brazilian Department of Agriculture
  22. 22. Corn EU Sales development and market share October 2015Investor Presentation22 259 297 314 324 321 10/11 11/12 12/13 13/14 14/15 Syngenta 6% Net sales* in € mn CAGR 5.5% Market share* 2014/2015 19% KWS Vilmorin 14% Others 24% 22% Pioneer 15% Monsanto EU acreage 13.6 mn ha * Preliminary data; Source: Kleffmann; own estimates KWS* Including sales with oilseeds & catch crops
  23. 23. Corn North America Sales development and market share October 2015Investor Presentation23 50:50-JV with Vilmorin, France 358 451 537 509 556 10/11 11/12 12/13 13/14 14/15 CAGR 11.6% Syngenta 5% *Preliminary data, KWS 7% AgReliant Dow 5% Others 16% 33% Pioneer Monsanto 34% US acreage 36.0 mn ha Net sales* in € mn Market share* 2014/2015 * Including sales with oilseeds & catch crops
  24. 24. Corn other regions Sales development October 2015Investor Presentation24 39 50 123 145 155 10/11 11/12 12/13 13/14 14/15 CAGR 41.2% 53% South Americas 30% European non EU states Asia/Africa 17% Sales € 155 mn Net sales* in € mn Sales breakdown 2014/2015 * Including sales with oilseeds & catch crops
  25. 25. Sugarbeet Segment
  26. 26. Sugarbeet segment sales October 2015 Total segment sales Potato 9% 91% Sugarbeet Segment sales 2014/2015 €390.5 mn Investor Presentation26
  27. 27. Sugarbeet worldwide Sales development and market share October 2015Investor Presentation27 1 Sugarbeet seeds w/o potato Net sales1 in € mn 267 281 298 319 364 10/11 11/12 12/13 13/14 14/15 CAGR 8.1% Global acreage: 4.0 mn ha (–4%) 26% KWS 17% SESVanderHave 16% Betaseed Strube 11% Desprez 5% Crystal 12% 2% Others Market share1,2 2014/2015 Syngenta 8% 2 Own data KWS, 2015 1 Sugarbeet seeds w/o potato Maribo 3%
  28. 28. Sugarbeet EU Sales development and market share October 2015 2 Own data KWS, 2014 1 Sugarbeet seeds w/o potato Investor Presentation28 132 129 128 137 136 10/11 11/12 12/13 13/14 14/15 CAGR 0.8% Net sales1 in € mn EU-acreage 2015: 1.4 mn ha (–14%) 20% SESVanderHave Maribo 4% Strube 18% Syngenta 6% Desprez 4% Betaseed 5% 2% Others Market share1,2 2014/2015 41% KWS 1 Sugarbeet seeds w/o potato
  29. 29. EU sugar market regime 2017 October 2015Investor Presentation29  Acreage expected to stay stable  Slight acreage expansion in competitive countries  Slight acreage reduction due to step-wise increase of isoglucose production  Higher sugar price volatility leads to higher acreage fluctuation  EU border protection is obtained
  30. 30. What lies ahead? – New research & breeding projects:  New breeding technologies (GABI)  KWS & Bayer  CONVISO® SMART (non-GMO herbicide resistance)  KWS & BASF  Yield genes (GMO)  Rizomania resistance (GMO virus resistance)  … Important sugarbeet research projects at KWS October 2015 KWS will remain no. 1 in innovations Investor Presentation30
  31. 31. Cereals Segment
  32. 32. KWS cereals activities October 2015 Acreage-related decline in hybrid rye business Investor Presentation32 78 93 112 107 111 10/11 11/12 12/13 13/14 14/15 CAGR 9.2% Net sales in € mn Wheat 21% Barley 20% Others 6% Rapeseed 10% Net sales breakdown by product group 43% Rye Segment sales 2014/2015 € 111.3 mn
  33. 33. KWS cereals activities October 2015 Takeover of the remaining 51% of shares in MOMONT, France Investor Presentation33
  34. 34. Research & Development
  35. 35. Research & development at KWS Base of a successful Corporate Development October 2015Investor Presentation35 R&D expenditure in € mn 114 127 140 150 174 0 50 100 150 200 10/11 11/12 12/13 13/14 14/15 CAGR 11.2% 13.3% 12.9% 12.2% 12.7% 13.8% 10/11 11/12 12/13 13/14 14/15 R&D intensity
  36. 36. Research & development at KWS Highly innovative and tailor-made October 2015Investor Presentation36 296 303 276 336 429 10/11 11/12 12/13 13/14 14/15 1,446 1,460 1,582 1,768 1,836 10/11 11/12 12/13 13/14 14/15 R&D employees Marketing approvals for new varieties
  37. 37. KWS: Global breeding October 2015Investor Presentation37 Breeding and distribution in over 70 countries Breeding stations Trial locations
  38. 38. Genetically engineered trait Lead gene identification Proof of concept Elite Event selection Deregulation Commerciali- zation Glyphosate tolerance Virus resistance Yield genes Glyphosate tolerance Glyphosate tolerance + Insect resistance Drought tolerance Nitrogen use efficiency Fungal resistance Fungal resistance KWS trait pipeline Progress by project October 2015Investor Presentation38
  39. 39. Corn traits from different companies October 2015Investor Presentation39 Trait Event Event name Monsanto Syngenta DuPont/Pioneer DOW Subterranean insect pests MON88017 YieldGard VT Rootworm D X MIR604 Agrisure RW D X 5307 Agrisure Duracade D 59122 Hercules RW, AcerMax RW X X D D MON87411 RNAi+Cry3Bb1 D X Aerial insect pests MON810 YieldGard D X Bt11 Agrisure TL, Agrisure CB/LL D TC1507 Herculex I, Herculex CB X D D MON89034 YieldGard VT (Double) Pro D X X MIR162 Agrisure Viptera X D X Herbicide tolerance GA21 Agrisure GT D NK603 Roundup Ready 2 D X X T25 Liberty Link X X X X DAS-4Ø278-9 Enlist X D D = Developer (2 „Ds“ in one row = joint development) X= Licensee
  40. 40. Employees October 2015Investor Presentation40 2014/2015 2013/2014 +/– Research & development 1,985 1,836 8.1% Distribution 1,259 1,241 1.5% Production 1,408 1,136 23.9% Administration 670 634 5.7% Total 5,322 4,847 9.8% Employees by function* 35% Americas Others 4% 26% Europe (w/o Germany) Employees by region* 35% Germany *On average for the year
  41. 41. Forecast 2014/2015 KWS Group in accordance with IFRS 11
  42. 42. Forecast 2015/2016 October 2015Investor Presentation42 KWS Group Sales EBIT margin R&D intensity 2015/2016 1,035 – 1,085 > 10.5% ~17% Forecast for the KWS Group in accordance with IFRS 11
  43. 43. Forecast 2015/2016 Segment report
  44. 44. Forecast 2015/2016 October 2015Investor Presentation44 2015/2016 2014/2015 Sales +10% to 15% € 754.4 mn EBIT margin around 11% 11.2% Corn 2015/2016 2014/2015 Sales at the level of the previous year € 390.5 mn EBIT margin at the level of the previous year 23.8% Sugarbeet 2015/2016 2014/2015 Sales slight growth € 111.3 mn EBIT margin below previous year 10.8% Cereals 2015/2016 2014/2015 Sales stable € 4.2 mn EBIT around –60 Mio. € € –51.2 mn Corporate
  45. 45. Appendix
  46. 46. Principles 46 1. We optimize genetic potential through excellent research and breeding programs. 2. We deliver best-quality seeds to our farmers. 3. We act as trusted performance partners for our farmers throughout their value chain. 4. In order to support talents at all levels to perform, we provide for entrepreneurial freedom. Mission KWS seeds the future. Our high-performing seeds and thorough knowledge of agriculture make us the trusted supplier for generations of farmers. This is our contribution in addressing growing global food demand. Vision October 2015Investor Presentation
  47. 47. The Executive Board October 2015 Dr. Hagen Duenbostel (1970)  CEO/Member of the Executive Board since 2003  Responsibility: Corn, Development & Communication, Compliance  Degree in Business Administration; Dr. rer. pol. Dr. Léon Broers (1960)  Member of the Executive Board since 2007  Responsibility: Research, Breeding  Ph.D. in Plant Breeding; Master of Business Administration Dr. Peter Hofmann (1960)  Member of the Executive Board since 2014  Responsibility: Sugarbeet, Cereals, Marketing  Degree in Agronomy; Ph.D. in Seed Physiology Eva Kienle (1967)  Member of the Executive Board since 2013  Responsibility: Finance, Law, Procurement, Controlling, IT, HR, Global Services, Investor Relations  Degree in Business Administration Investor Presentation47
  48. 48. The KWS share October 2015 Shareholder structure No. of shares: 6,600,000 56.0% Families Büchting Arend Oetker Giesecke 15.1% Tessner Beteiligungs GmbH Free float 28.9% Key figures per October 8, 2015 (Xetra) Closing call: €301.00 Market Cap.: €1.99 bn Free Float Market Cap.: €572 mn 52 weeks high/low: €313.55/€257.00 WKN: 707400 ISIN: DE0007074007 Symbol: KWS Investor Presentation48
  49. 49. Financial calendar & IR contact October 2015Investor Presentation49 Date November 24, 2015 Report on the 1st quarter of 2015/2016 December 17, 2015 Annual Shareholders’ Meeting in Einbeck February 25, 2016 Report on the 2nd quarter of 2015/2016 May 26, 2016 Report on the 3rd quarter of 2015/2016 October 25, 2016 Publication of 2015/2016 financial statements, annual press and analyst conference in Frankfurt December 15, 2016 Annual Shareholders’ Meeting in Einbeck Financial calendar Wolf-Gebhard von der Wense Head of Investor Relations +49 (0) 5561 311-968 investor.relations@kws.com KWS SAAT SE Grimsehlstr. 31 37574 Einbeck Lisa Bertram Investor Relations +49 (0) 5561 311-14 97 investor.relations@kws.com KWS SAAT SE Grimsehlstr. 31 37574 Einbeck
  50. 50. Disclaimer October 2015 These materials are not an offer for sale of Subscription rights or Securities in the United States. Subscription rights and Securities may not be offered or sold in the United States without registration or an exemption from registration under the U.S Securities Act of 1993, as amended. KWS SAAT SE does not intend to register any portion of the offering in the United States or to conduct a public offering in the United States or to conduct a public offering of Subscription rights or Securities in the United States. This document contains certain forward-looking statements relating to the business, financial performance and results of KWS SAAT SE and/or its subsidiaries and/or the industry in which KWS SAAT SE and its subsidiaries operate. These forward-looking statements are based on KWS’ current plans, estimates, projections and expectations. These statements are based on certain assumptions that, although reasonable at this time, may prove to be erroneous. Prospective investors should not place undue reliance on these forward-looking statements. If certain risks and uncertainties materialize, or if certain underlying assumptions prove incorrect, events described in this document as anticipated, believed, estimated or expected may not occur, and KWS SAAT SE may not be able to achieve its financial targets and strategic objectives. This presentation should not be viewed as definitive legal, tax, or other advice regarding investment. All interested investors should seek independent third party legal, tax, and other advice. KWS SAAT SE does not intend, and does not assume any obligations, to update industry information or forward-looking statements set forth in this document. KWS SAAT SE assumes no responsibility or liability in regard to the completeness of the contents and the accuracy of opinions, estimates, prognoses, calculations, or other information contained in this presentation. This presentation may contain confidential information. Neither the presentation nor any of its contents may be reproduced or otherwise made available to third parties. Investor Presentation50

×